Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

Clinical trial NCT05220722 · TERMINATED

Trial details

NCT number: NCT05220722
Sponsor: TriSalus Life Sciences, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Intrahepatic Cholangiocarcinoma

Start date: 2022-03-02
Primary completion: 2024-07-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.